Annual Retained Earnings
-$436.29 M
-$8.24 M-1.92%
December 31, 2023
Summary
- As of February 26, 2025, MRKR annual retained earnings is -$436.29 million, with the most recent change of -$8.24 million (-1.92%) on December 31, 2023.
- During the last 3 years, MRKR annual retained earnings has fallen by -$80.05 million (-22.47%).
- MRKR annual retained earnings is now -28156.86% below its all-time high of -$1.54 million, reached on December 31, 1999.
Performance
MRKR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$443.18 M
-$2.31 M-0.52%
September 30, 2024
Summary
- As of February 26, 2025, MRKR quarterly retained earnings is -$443.18 million, with the most recent change of -$2.31 million (-0.52%) on September 30, 2024.
- Over the past year, MRKR quarterly retained earnings has dropped by -$2.31 million (-0.52%).
- MRKR quarterly retained earnings is now -26153.16% below its all-time high of -$1.69 million, reached on December 31, 2001.
Performance
MRKR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
MRKR Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.9% | -0.5% |
| 3 y3 years | -22.5% | -0.5% |
| 5 y5 years | -42.5% | -30.2% |
MRKR Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.6% | at low | -11.3% | at low |
| 5 y | 5-year | -33.2% | at low | -35.3% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Marker Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$443.18 M(+0.5%) |
| Jun 2024 | - | -$440.87 M(+0.5%) |
| Mar 2024 | - | -$438.68 M(+0.5%) |
| Dec 2023 | -$436.29 M(+1.9%) | -$436.29 M(+0.6%) |
| Sep 2023 | - | -$433.48 M(+0.7%) |
| Jun 2023 | - | -$430.50 M(-0.6%) |
| Mar 2023 | - | -$433.02 M(+1.2%) |
| Dec 2022 | -$428.05 M(+7.5%) | -$428.05 M(+0.9%) |
| Sep 2022 | - | -$424.19 M(+1.7%) |
| Jun 2022 | - | -$417.27 M(+2.3%) |
| Mar 2022 | - | -$408.03 M(+2.5%) |
| Dec 2021 | -$398.12 M(+11.8%) | -$398.12 M(+2.5%) |
| Sep 2021 | - | -$388.36 M(+3.3%) |
| Jun 2021 | - | -$375.93 M(+3.0%) |
| Mar 2021 | - | -$365.02 M(+2.5%) |
| Dec 2020 | -$356.24 M(+8.8%) | -$356.24 M(+2.4%) |
| Sep 2020 | - | -$347.73 M(+2.2%) |
| Jun 2020 | - | -$340.36 M(+1.9%) |
| Mar 2020 | - | -$334.02 M(+2.0%) |
| Dec 2019 | -$327.53 M(+7.0%) | -$327.53 M(+1.6%) |
| Sep 2019 | - | -$322.45 M(+1.7%) |
| Jun 2019 | - | -$316.99 M(+1.8%) |
| Mar 2019 | - | -$311.42 M(+1.7%) |
| Dec 2018 | -$306.11 M(+94.5%) | -$306.11 M(+79.5%) |
| Sep 2018 | - | -$170.55 M(+2.6%) |
| Jun 2018 | - | -$166.16 M(+3.4%) |
| Mar 2018 | - | -$160.62 M(+2.0%) |
| Dec 2017 | -$157.42 M(+8.0%) | -$157.42 M(+1.7%) |
| Sep 2017 | - | -$154.74 M(+2.6%) |
| Jun 2017 | - | -$150.75 M(+1.7%) |
| Mar 2017 | - | -$148.24 M(+1.7%) |
| Dec 2016 | -$145.82 M(+9.2%) | -$145.82 M(+1.1%) |
| Sep 2016 | - | -$144.24 M(+9.0%) |
| Jun 2016 | - | -$132.28 M(-4.3%) |
| Mar 2016 | - | -$138.26 M(+3.6%) |
| Dec 2015 | -$133.51 M(+54.7%) | -$133.51 M(+29.3%) |
| Sep 2015 | - | -$103.25 M(-2.3%) |
| Jun 2015 | - | -$105.74 M(+21.1%) |
| Mar 2015 | - | -$87.29 M(+1.1%) |
| Dec 2014 | -$86.31 M(+55.7%) | -$86.31 M(+0.9%) |
| Sep 2014 | - | -$85.57 M(+1.4%) |
| Jun 2014 | - | -$84.38 M(-0.9%) |
| Mar 2014 | - | -$85.13 M(+53.6%) |
| Dec 2013 | -$55.43 M(+11.1%) | -$55.43 M(+6.7%) |
| Sep 2013 | - | -$51.95 M(+1.5%) |
| Jun 2013 | - | -$51.21 M(+1.1%) |
| Mar 2013 | - | -$50.66 M(+1.5%) |
| Dec 2012 | -$49.89 M | -$49.89 M(+4.3%) |
| Sep 2012 | - | -$47.84 M(+1.6%) |
| Jun 2012 | - | -$47.07 M(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | -$44.32 M(+1.4%) |
| Dec 2011 | -$43.72 M(+4.9%) | -$43.72 M(-4.7%) |
| Sep 2011 | - | -$45.88 M(+40.5%) |
| Jun 2011 | - | -$32.67 M(+1.3%) |
| Mar 2011 | - | -$32.26 M(-22.6%) |
| Dec 2010 | -$41.69 M(+8.5%) | -$41.69 M(+42.0%) |
| Sep 2010 | - | -$29.35 M(+4.1%) |
| Jun 2010 | - | -$28.21 M(+4.8%) |
| Mar 2010 | - | -$26.91 M(-29.9%) |
| Dec 2009 | -$38.41 M(+84.6%) | -$38.41 M(+75.1%) |
| Sep 2009 | - | -$21.94 M(+3.7%) |
| Jun 2009 | - | -$21.15 M(-0.5%) |
| Mar 2009 | - | -$21.26 M(+2.2%) |
| Dec 2008 | -$20.81 M(+11.8%) | -$20.81 M(+2.4%) |
| Sep 2008 | - | -$20.32 M(+1.3%) |
| Jun 2008 | - | -$20.05 M(+3.9%) |
| Mar 2008 | - | -$19.29 M(+3.6%) |
| Dec 2007 | -$18.62 M(+26.4%) | -$18.62 M(+6.3%) |
| Sep 2007 | - | -$17.51 M(+3.2%) |
| Jun 2007 | - | -$16.95 M(+5.0%) |
| Mar 2007 | - | -$16.14 M(+9.6%) |
| Dec 2006 | -$14.72 M(+9.7%) | -$14.72 M(+2.0%) |
| Sep 2006 | - | -$14.44 M(+3.0%) |
| Jun 2006 | - | -$14.02 M(+1.7%) |
| Mar 2006 | - | -$13.79 M(+2.7%) |
| Dec 2005 | -$13.42 M(+7.9%) | -$13.42 M(+1.4%) |
| Sep 2005 | - | -$13.23 M(+2.4%) |
| Jun 2005 | - | -$12.92 M(+3.7%) |
| Mar 2005 | - | -$12.46 M(+0.2%) |
| Dec 2004 | -$12.43 M(+27.5%) | -$12.43 M(+9.6%) |
| Sep 2004 | - | -$11.34 M(+3.7%) |
| Jun 2004 | - | -$10.94 M(+5.0%) |
| Mar 2004 | - | -$10.42 M(+6.9%) |
| Dec 2003 | -$9.75 M(+145.5%) | -$9.75 M(+36.9%) |
| Sep 2003 | - | -$7.12 M(+16.2%) |
| Jun 2003 | - | -$6.13 M(+26.4%) |
| Mar 2003 | - | -$4.85 M(+22.0%) |
| Dec 2002 | -$3.97 M(+135.3%) | -$3.97 M(+40.4%) |
| Sep 2002 | - | -$2.83 M(-36.1%) |
| Jun 2002 | - | -$4.43 M(+28.9%) |
| Mar 2002 | - | -$3.43 M(+103.5%) |
| Dec 2001 | -$1.69 M(-40.5%) | -$1.69 M(-46.9%) |
| Sep 2001 | - | -$3.18 M(+1.8%) |
| Jun 2001 | - | -$3.12 M(-3.7%) |
| Mar 2001 | - | -$3.24 M(+14.3%) |
| Dec 2000 | -$2.84 M(+83.7%) | -$2.84 M(+12.7%) |
| Sep 2000 | - | -$2.52 M(+17.9%) |
| Jun 2000 | - | -$2.13 M(+16.7%) |
| Mar 2000 | - | -$1.83 M |
| Dec 1999 | -$1.54 M | - |
FAQ
- What is Marker Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Marker Therapeutics?
- What is Marker Therapeutics annual retained earnings year-on-year change?
- What is Marker Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Marker Therapeutics?
- What is Marker Therapeutics quarterly retained earnings year-on-year change?
What is Marker Therapeutics annual retained earnings?
The current annual retained earnings of MRKR is -$436.29 M
What is the all time high annual retained earnings for Marker Therapeutics?
Marker Therapeutics all-time high annual retained earnings is -$1.54 M
What is Marker Therapeutics annual retained earnings year-on-year change?
Over the past year, MRKR annual retained earnings has changed by -$8.24 M (-1.92%)
What is Marker Therapeutics quarterly retained earnings?
The current quarterly retained earnings of MRKR is -$443.18 M
What is the all time high quarterly retained earnings for Marker Therapeutics?
Marker Therapeutics all-time high quarterly retained earnings is -$1.69 M
What is Marker Therapeutics quarterly retained earnings year-on-year change?
Over the past year, MRKR quarterly retained earnings has changed by -$2.31 M (-0.52%)